Healthspan Capital
- Company typePrivate
- Founded2021
- HeadquartersEl Cerrito, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
Healthspan Capital firmographics
Firmographics- Name
- Healthspan Capital
- Legal name
- Healthspan Capital
- Website
- https://healthspancapital.vc
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Where Healthspan Capital is headquartered
LocationHeadquarters
- HQ city
- El Cerrito
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Healthspan Capital business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Venture Fund Management: Healthspan Capital generates revenue through management fees (2% of committed capital) and performance-based carry (20% of profits) from its rolling fund structure. The firm raises capital from accredited investors through quarterly subscriptions on AngelList and deploys it into early-stage longevity biotech companies.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Rolling Fund Investment |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels8 records
Healthspan Capital product offering
Product offeringCore offering
Healthspan Capital manages a rolling venture fund on AngelList that invests in early-stage longevity biotechnology companies (pre-Seed to Series A) developing therapeutics targeting the biology of aging. Accredited investors can subscribe quarterly with a $5,000 minimum, paying a 2% management fee and 20% carry. The firm also provides portfolio companies with capital, strategic guidance, and access to a network of longevity biotech advisors and founders.
Product overview
Healthspan Capital is a venture capital firm structured as an AngelList rolling fund that provides accredited investors access to early-stage longevity biotechnology companies. The firm invests in pre-Seed to Series A companies developing therapeutics targeting aging. The product offering consists of the Healthspan Capital Rolling Fund, which enables simple and flexible investment in longevity biotech through AngelList, with a minimum investment of $5,000 USD and a fee structure of 20% carry and 2% management fee.
Differentiator
Problem solved
Functional benefit
Products and services
- Healthspan Capital Rolling Fund An AngelList rolling venture fund that invests in early-stage longevity biotechnology (LongBio) companies (pre-Seed to Series A) developing therapeutics targeting the biology of aging. Available to accredited investors with a $5,000 minimum quarterly subscription and a 2% management fee / 20% carry fee structure.
Companies that use Healthspan Capital
Customer profileSegments2 records
Ideal customer profiles2 records
Healthspan Capital technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Healthspan Capital partnerships and signals
Strategic signalScale indicators4 records
Recent moves5 records
Expansion highlights5 records
Healthspan Capital competitors and assessment
Company assessmentBroad incumbents
- RA Capital Management: Healthcare and biotech-focused crossover fund that invests in therapeutic developers, including longevity-adjacent companies; comparable in life-sciences expertise but at larger scales and later stages.
- Khosla Ventures: Large venture firm with significant longevity and biotech exposure; competes for similar deals at later stages and has substantially larger check sizes and AUM.
- BOLD Capital Partners: Deep-tech and longevity-focused venture firm with broader portfolio scope and larger fund sizes; overlaps with Healthspan Capital in longevity thesis but operates as a more generalist deep-tech investor.
- ARCH Venture Partners: Established biotech-focused venture firm that has backed several longevity and anti-aging companies; a broader incumbent with deeper follow-on capacity and institutional LP base.
Direct peers
- The Longevity Fund: Early-stage venture fund investing in longevity and healthy-lifespan extension startups, with comparable stage focus and a similar GP-led model.
- Cambrian Biopharma: Multi-program longevity biotech holding company co-founded by Healthspan co-founder Sebastian Brunemeier; comparable in sector focus, though structured as a builder/holding company rather than a fund.
- Apollo Health Ventures: Europe-based early-stage venture fund focused on aging and longevity therapeutics — directly comparable to Healthspan Capital in stage focus, sector specialization, and GP-driven origination model.
- Methuselah Fund: Longevity-focused investment fund associated with the Methuselah Foundation; targets tissue engineering, regenerative medicine, and aging therapeutics at similar early stages.
- Longevity Vision Fund: Venture fund founded by Sergey Young focused on longevity and life-extension technologies, investing across the longevity stack at early and growth stages.
Emerging players
- Korify Capital: Early-stage investor in deep tech and life sciences including longevity; comparable in stage and thematic focus but with a broader life-sciences remit.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Healthspan Capital social profiles
Digital presenceHealthspan Capital financial estimates
Financial estimateRevenue estimate
Valuation estimate
Healthspan Capital leadership team
Management profileNumber of profiles
Profiles3 records
Healthspan Capital funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Healthspan Capital M&A and investment
M&A and investmentM&A
Investments22 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Healthspan Capital
What does Healthspan Capital do?
Healthspan Capital manages a rolling venture fund on AngelList that invests in early-stage longevity biotechnology companies (pre-Seed to Series A) developing therapeutics targeting the biology of aging. Accredited investors can subscribe quarterly with a $5,000 minimum, paying a 2% management fee and 20% carry. The firm also provides portfolio companies with capital, strategic guidance, and access to a network of longevity biotech advisors and founders.
Is Healthspan Capital a public or private company?
Healthspan Capital is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Healthspan Capital founded?
Healthspan Capital was founded in 2021. It employs 1 to 10 people.
Where is Healthspan Capital based?
Healthspan Capital is headquartered in El Cerrito, United States, in the North America region.
How does Healthspan Capital make money?
One revenue line is on record: venture Fund Management.
Who are Healthspan Capital's main competitors?
Broad incumbents on record are RA Capital Management, Khosla Ventures, BOLD Capital Partners and ARCH Venture Partners. Direct peers are The Longevity Fund, Cambrian Biopharma, Apollo Health Ventures, Methuselah Fund and Longevity Vision Fund. Korify Capital is listed as an emerging player.
Does Healthspan Capital have an API?
No public API is recorded for Healthspan Capital.